Engineering PAMAM dendrimers for optimized drug delivery
Dendrimers, first introduced by Fritz Vögtle in 1978, have emerged as promising nanocarriers for drug delivery due to their unique branched architecture, large internal cavities, and numerous surface amine groups. These dendrimers efficiently load various drugs through electrostatic interactions, co...
Main Authors: | Amin Aleebrahim Dehkordi, Shirin Mollazadeh, Amirreza Talaie, Mostafa Yazdimamaghani |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-03-01
|
Series: | Nano Trends |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666978125000236 |
Similar Items
-
New Advances in General Biomedical Applications of PAMAM Dendrimers
by: Renan Vinicius de Araújo, et al.
Published: (2018-11-01) -
High Fluorescent Porphyrin-PAMAM-Fluorene Dendrimers
by: Karla I. Garfias-Gonzalez, et al.
Published: (2015-05-01) -
Vismodegib in PAMAM-dendrimers for potential theragnosis in skin cancer
by: David E. Ybarra, et al.
Published: (2022-07-01) -
PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review
by: Fana M, et al.
Published: (2020-04-01) -
Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer
by: Ayuob Aghanejad, et al.
Published: (2025-01-01)